experspadmin

Hemoglobin A Clearance in Sickle Cell Disease
Hematology

Hemoglobin A Clearance in Sickle Cell Disease

clinical topic updates
By Stella T. Chou, MD
Biologic Switching in the Treat-to-Target Paradigm of Plaque Psoriasis
Dermatology

Biologic Switching in the Treat-to-Target Paradigm of Plaque Psoriasis

expert roundtables
By Alice B. Gottlieb, MD, PhD; Joel M. Gelfand, MD, MSCE; Steven R. Feldman, MD, PhD
Targeted Therapies for Migraine
Neurology

Targeted Therapies for Migraine

expert roundtables
By David W. Dodick, MD; Deborah I. Friedman, MD, MPH, FAAN, FAHS; Paul G. Mathew, MD, DNBPAS, FAAN, FAHS
Next Steps After Inadequate Response to Established Tyrosine Kinase Inhibitors
Oncology

Next Steps After Inadequate Response to Established Tyrosine Kinase Inhibitors

patient care perspectives
By Neil P. Shah, MD, PhD
Approach to Patients With a High Number of Vaso-Occlusive Crises in the Past Year
Hematology

Approach to Patients With a High Number of Vaso-Occlusive Crises in the Past Year

expert roundtables
By Julie Kanter, MD; Michael Rutledge DeBaun, MD, MPH; Stella T. Chou, MD
Load More